SBC Medical Group Holdings Inc(SBC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 9.33 | EPS (ttm) | 0.48 | Insider Own | 81.55% | Shs Outstand | 102.6M | Perf Week | 4.21% |
| Market Cap | 0.46B | Forward P/E | 8.52 | EPS next Y | 14.26% | Insider Trans | -4.08% | Shs Float | 19.0M | Perf Month | 39.37% |
| Enterprise Value | 0.34B | PEG | 6.46 | EPS next Q | 0.12 | Inst Own | 4.28% | Short Float | 3.67% | Perf Quarter | 49.16% |
| Income | 0.05B | P/S | 2.62 | EPS this Y | -8.4% | Inst Trans | 133.44% | Short Ratio | 4.91 | Perf Half Y | 26.35% |
| Sales | 0.18B | P/B | 1.73 | EPS next 5Y | 1.32% | ROA | 13.58% | Short Interest | 0.70M | Perf YTD | 3.48% |
| Book/sh | 2.57 | P/C | 2.48 | EPS past 3/5Y | 138.04% - | ROE | 19.29% | 52W High | -10.26% ($4.97) | Perf Year | -0.67% |
| Cash/sh | 1.8 | P/FCF | 6.12 | Sales past 3/5Y | - | ROIC | 16.63% | 52W Low | 60.43% ($2.78) | Perf 3Y | -57.96% |
| Dividend Est. | - | EV/EBITDA | 4.93 | EPS Y/Y TTM | 46.87% | Gross Margin | 71.02% | Volatility(W/M) | 4.78% 6.01% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1.93 | Sales Y/Y TTM | -6.92% | Oper. Margin | 37.34% | ATR (14) | 0.19 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.2 | EPS Q/Q | 337.82% | Profit Margin | 27.99% | RSI (14) | 68.74 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.31 | Sales Q/Q | 13.44% | SMA20 | 9.29% ($4.08) | Beta | 0.58 | Target Price | $8.75 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2026/8/13 | SMA50 | 28.19% ($3.48) | Rel Volume | 1.29 | Prev Close | $4.4 |
| Employees | 863 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | -13.87% 8.41% | SMA200 | 19.57% ($3.73) | Avg Volume(3M) | 0.14M | Price | $4.46 |
| IPO | 2022/9/26 | Option/Short | Yes/Yes | Trades | 2164 | Volume | 182,618 | Change | 1.36% |
Company
SBC is a Industrials sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💉 A healthcare operations support company that provides management services to a network of beauty and dermatology treatment clinics, primarily in Japan. Its business model is designed to enhance the operational efficiency of affiliated medical corporations through franchise operations, equipment and consumables procurement, and facility leasing. The company is listed on a US stock exchange.
Over the past 1 year, on the higher side
10% below its 1-year high.
SBC makes money exceptionally well
37.34% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -8.4% this year.
Tap to view numbers
The stock looks undervalued
Trading at 9.3 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are close to the market
Would have changed by -58.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 4.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IWC 0.00%
FLQS 0.00%
HDG 0.00%
HONG 0.00%
ITWO 0.00%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
HSBH 1MIt ranks #4 in the industry
Based on market cap of $459M.
SBC $459M PER 9.3
VRSK $23B PER 27.1
EFX $20B PER 29.7
BAH $9B PER 11.9
FAQ
What kind of company is SBC?
SBC belongs to the Industrials sector and operates in the Consulting Services industry.
What is the market cap of SBC?
The market cap of SBC is approximately $459M, ranking 3,300 within its sector.
What is the P/E ratio of SBC?
SBC has a P/E ratio of approximately 9.3x, which can be used to assess its valuation relative to the Industrials sector average.
What is the 52-week high and low for SBC?
SBC has recorded a 52-week high of $4.97 and a low of $2.78.
